Recall: D-0560-2022

Class II - Potentially Harmful

Class IIClassification
2022-01-14Initiated
TerminatedStatus
Aurobindo Pharma USA Inc.Firm

Product

Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03

Reason

Failed Impurities/Degradation Specifications

Distribution

USA Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.